BI Focuses COVID-19 Clinical Research on Alteplase
BI focuses its COVID-19 therapy research on the development of alteplase as a potential treatment for COVID-19 patients with severe breathing problems
Search
Summary_of_the_conclusions_of_the_expert_working_group_of_alteplase.pdf
Acute Ischaemic Stroke
Acute Ischaemic Stroke
Boehringer-Ingelheim's-half-year-figures-2021
Press release on Boehringer Ingelheim's half-year figures 2021. Business development from January to June 2021.